![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/46 | |
A61P 35/00 | |||
C07H 21/04 | |||
C12N 1/21 | |||
C12N 15/63 | |||
C12N 9/82 | |||
C12P 1/04 |
(11) | Number of the document | 2046369 |
(13) | Kind of document | T |
(96) | European patent application number | 07840229.4 |
Date of filing the European patent application | 2007-06-08 | |
(97) | Date of publication of the European application | 2009-04-15 |
(45) | Date of publication and mention of the grant of the patent | 2015-08-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/070706 |
Date | 2007-06-08 |
(87) | Number | WO 2008/011234 |
Date | 2008-01-24 |
(30) | Number | Date | Country code |
817817 P | 2006-06-30 | US |
(72) |
FILPULA, David R., US
WANG, Maoliang, US
|
(73) |
Sigma-Tau Pharma Limited,
21 Holborn Viaduct, London EC1A 2DY,
GB
|
(54) | RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II |
RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II |